- Corporate Officers - M
- Mendel Scott
Insider Trading History of Mendel Scott
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mendel Scott since 2011.
This trader's CIK number is 1515051.
At the time of last reporting, Mendel Scott was the Officer of Akoya Biosciences, Inc.. (stock ticker symbol AKYA).
Also see all insider trading activities at Akoya Biosciences, Inc..
Note that in the past
Mendel Scott also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Akoya Biosciences, Inc. (AKYA) by Mendel Scott
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | AKYA | 20,000 | $100,000 | 0 | $0 | 0 | $0 |
2021 | AKYA | 8,500 | $111,860 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Genmark Diagnostics, Inc. (GNMK) by Mendel Scott
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | GNMK | 0 | $0 | 114,975 | $1,651,594 | 146,172 | $0 |
2020 | GNMK | 0 | $0 | 149,497 | $1,911,252 | 17,697 | $0 |
2019 | GNMK | 0 | $0 | 37,911 | $236,625 | 12,800 | $0 |
2018 | GNMK | 0 | $0 | 21,840 | $117,964 | 0 | $0 |
2017 | GNMK | 0 | $0 | 32,802 | $337,441 | 22,564 | $0 |
2016 | GNMK | 0 | $0 | 0 | $0 | 298 | $0 |
2015 | GNMK | 20,000 | $155,700 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Active Network Inc (ACTV) by Mendel Scott
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2012 | ACTV | 10,000 | $56,200 | 52,905 | $872,565 | 52,905 | $175,607 |
2011 | ACTV | 0 | $0 | 52,016 | $780,240 | 60,353 | $206,105 |
Insider trading activities at 3 companies by Mendel Scott:
1. Akoya Biosciences, Inc. (AKYA)
2. Genmark Diagnostics, Inc. (GNMK)
3. Active Network Inc (ACTV)
Table 1. Insider trading of Akoya Biosciences, Inc. (AKYA) by Mendel Scott
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-06-12 | AKYA | Buy | 20,000 | 5.00 | 100,000 |
2021-11-19 | AKYA | Buy | 8,500 | 13.16 | 111,860 |
Table 2. Insider trading of Genmark Diagnostics, Inc. (GNMK) by Mendel Scott
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-01-25 | GNMK | Sale | 64,975 | 14.23 | 924,594 |
2021-01-21 | GNMK | Option Ex | 146,172 | .00 | 0 |
2021-01-19 | GNMK | Sale | 50,000 | 14.54 | 727,000 |
2020-11-24 | GNMK | Sale | 5,190 | 13.17 | 68,352 |
2020-11-19 | GNMK | Sale | 3,987 | 13.85 | 55,219 |
2020-08-26 | GNMK | Sale | 50,000 | 15.02 | 751,000 |
2020-08-25 | GNMK | Sale | 4,532 | 14.14 | 64,082 |
2020-08-20 | GNMK | Sale | 2,988 | 15.41 | 46,045 |
2020-08-12 | GNMK | Sale | 50,000 | 15.08 | 754,000 |
2020-05-28 | GNMK | Sale | 3,751 | 9.52 | 35,709 |
2020-05-19 | GNMK | Sale | 2,800 | 10.46 | 29,288 |
2020-02-27 | GNMK | Sale | 2,659 | 3.51 | 9,333 |
2020-02-25 | GNMK | Sale | 1,402 | 3.81 | 5,341 |
2020-02-20 | GNMK | Sale | 14,536 | 3.80 | 55,236 |
2020-01-23 | GNMK | Sale | 7,652 | 4.92 | 37,647 |
2020-01-23 | GNMK | Option Ex | 17,697 | .00 | 0 |
2019-11-25 | GNMK | Sale | 5,206 | 5.43 | 28,268 |
2019-11-20 | GNMK | Sale | 2,701 | 5.55 | 14,990 |
2019-08-27 | GNMK | Sale | 3,685 | 6.03 | 22,220 |
2019-08-20 | GNMK | Sale | 1,967 | 6.25 | 12,293 |
2019-05-30 | GNMK | Sale | 2,304 | 6.60 | 15,206 |
2019-05-24 | GNMK | Sale | 1,371 | 6.62 | 9,076 |
2019-05-21 | GNMK | Sale | 1,907 | 6.83 | 13,024 |
2019-02-25 | GNMK | Sale | 11,410 | 6.80 | 77,588 |
2019-02-20 | GNMK | Sale | 2,063 | 6.16 | 12,708 |
2019-01-23 | GNMK | Sale | 5,297 | 5.90 | 31,252 |
2019-01-17 | GNMK | Option Ex | 12,800 | .00 | 0 |
2018-11-27 | GNMK | Sale | 1,292 | 5.08 | 6,563 |
2018-11-20 | GNMK | Sale | 1,959 | 4.84 | 9,481 |
2018-11-05 | GNMK | Sale | 226 | 4.85 | 1,096 |
2018-08-24 | GNMK | Sale | 1,361 | 7.16 | 9,744 |
2018-08-21 | GNMK | Sale | 1,915 | 7.39 | 14,151 |
2018-08-03 | GNMK | Sale | 207 | 7.20 | 1,490 |
2018-05-23 | GNMK | Sale | 1,312 | 6.88 | 9,026 |
2018-05-21 | GNMK | Sale | 1,904 | 6.91 | 13,156 |
2018-05-15 | GNMK | Sale | 1,218 | 6.60 | 8,038 |
2018-05-02 | GNMK | Sale | 218 | 6.18 | 1,347 |
2018-02-26 | GNMK | Sale | 6,275 | 4.17 | 26,166 |
2018-02-20 | GNMK | Sale | 2,304 | 4.37 | 10,068 |
2018-02-14 | GNMK | Sale | 1,391 | 4.54 | 6,315 |
2018-02-02 | GNMK | Sale | 258 | 5.13 | 1,323 |
2017-11-20 | GNMK | Sale | 2,879 | 4.74 | 13,646 |
2017-11-14 | GNMK | Sale | 1,777 | 4.71 | 8,369 |
2017-11-02 | GNMK | Sale | 326 | 7.24 | 2,360 |
2017-08-21 | GNMK | Sale | 2,898 | 9.45 | 27,386 |
2017-08-15 | GNMK | Sale | 1,752 | 10.16 | 17,800 |
2017-08-02 | GNMK | Sale | 333 | 10.33 | 3,439 |
2017-05-19 | GNMK | Sale | 2,135 | 12.89 | 27,520 |
2017-05-16 | GNMK | Sale | 1,268 | 13.43 | 17,029 |
2017-05-02 | GNMK | Sale | 232 | 13.34 | 3,094 |
2017-02-21 | GNMK | Sale | 8,595 | 10.08 | 86,637 |
2017-02-14 | GNMK | Sale | 1,274 | 10.98 | 13,988 |
2017-02-02 | GNMK | Sale | 235 | 11.58 | 2,721 |
2017-01-19 | GNMK | Option Ex | 22,564 | .00 | 0 |
2017-01-19 | GNMK | Sale | 9,098 | 12.47 | 113,452 |
2016-01-21 | GNMK | Option Ex | 298 | .00 | 0 |
2015-10-30 | GNMK | Buy | 10,000 | 6.47 | 64,700 |
2015-08-24 | GNMK | Buy | 10,000 | 9.10 | 91,000 |
Table 3. Insider trading of Active Network Inc (ACTV) by Mendel Scott
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2012-11-06 | ACTV | Buy | 10,000 | 5.62 | 56,200 |
2012-03-09 | ACTV | Option Ex | 49,426 | 3.42 | 168,789 |
2012-03-09 | ACTV | Sale | 49,426 | 16.49 | 815,232 |
2012-02-24 | ACTV | Option Ex | 3,479 | 1.96 | 6,818 |
2012-02-24 | ACTV | Sale | 3,479 | 16.48 | 57,333 |
2011-05-31 | ACTV | Sale | 52,016 | 15.00 | 780,240 |
2011-05-31 | ACTV | Option Ex | 60,353 | 3.42 | 206,105 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Mendel Scott
(Officer of Akoya Biosciences, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.